Eutherva Medicament Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.48 Cr
- Satisfied Charges ₹ 0.50 M
- Revenue Growth 32.13%
- Profit Growth -9.17%
- Ebitda 14.04%
- Net Worth 2.34%
- Total Assets -6.81%
About Eutherva Medicament
Eutherva Medicament Private Limited (EMPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 May 2004 and has a history of 20 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.48 Cr. The company has closed loans amounting to ₹0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Madhav Deshpande and Mukund Deshpande serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH2004PTC146417
- Company No.
146417
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Eutherva Medicament Private Limited offer?
Eutherva Medicament Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine.
Who are the key members and board of directors at Eutherva Medicament?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhav Deshpande  | Director | 19-May-2004 | Current |
| Mukund Deshpande | Director | 19-May-2004 | Current |
Financial Performance of Eutherva Medicament.
Eutherva Medicament Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.13% increase. The company also saw a slight decrease in profitability, with a 9.17% decrease in profit. The company's net worth moved up by a moderate rise of 2.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eutherva Medicament?
In 2020, Eutherva Medicament had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹14.80 M
₹0.50 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.35 Cr
- Can Bank Factors Ltd. : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 May 2006 | State Bank Of India | ₹6.75 M | Open |
| 12 May 2006 | State Bank Of India | ₹6.75 M | Open |
| 29 Sep 1997 | Can Bank Factors Ltd. | ₹1.30 M | Open |
| 23 Mar 2005 | The Bharat Co- Op. Bank Ltd. | ₹0.50 M | Satisfied |
How Many Employees Work at Eutherva Medicament?
Eutherva Medicament has a workforce of 5 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eutherva Medicament, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eutherva Medicament's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.